Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein-protein interactions: lessons learned.

S K Sharma1, T M Ramsey, K W Bair

  • 1Oncology Department, Novartis Institute for Biomedical Research, 556 Morris Avenue, Summit, NJ 07901, USA. sushil.sharma@pharma.novartis.com

Current Medicinal Chemistry. Anti-Cancer Agents
|April 8, 2003
PubMed
Summary

This review explores protein-protein interactions, crucial for cell function and cancer. It details strategies for discovering anti-tumor drugs targeting these interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis and antitumor activity of ester-modified analogues of bengamide B.

Journal of medicinal chemistry·2001
Same author

Identification of E2F-1/Cyclin A antagonists.

Bioorganic & medicinal chemistry letters·2001
Same author

Total syntheses of bengamides B and E.

The Journal of organic chemistry·2001
Same author

Bengamides revisited: new structures and antitumor studies.

The Journal of organic chemistry·2001
Same author

Solid-phase total synthesis of polymyxin B1.

The journal of peptide research : official journal of the American Peptide Society·1999
Same author

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists.

Proceedings of the National Academy of Sciences of the United States of America·1999

Area of Science:

  • Biochemistry and Molecular Biology
  • Drug Discovery and Development
  • Oncology

Background:

  • Protein-protein (P-P) interactions are fundamental to cellular structure and processes.
  • The complexity of P-P interactions remains a significant challenge in biological research.
  • Aberrant P-P interactions are implicated in the pathogenesis of various diseases, notably cancer.

Purpose of the Study:

  • To review the physical forces governing P-P interaction affinity and specificity.
  • To examine classical and novel strategies for discovering inhibitors of P-P interactions.
  • To highlight recent advancements in developing anti-tumor drugs targeting P-P interactions, with case studies.

Main Methods:

  • Literature review of P-P interaction research.
  • Analysis of physical principles underlying protein binding.
  • Evaluation of drug discovery methodologies for P-P interaction inhibitors.
  • Case study analysis of cancer-related P-P interactions and drug development.

Main Results:

  • Detailed examination of forces (e.g., hydrophobic, electrostatic) dictating P-P binding.
  • Comparison of established and emerging techniques for identifying P-P interaction inhibitors.
  • Illustrative examples of successful and ongoing drug discovery efforts targeting P-P interactions in cancer.

Conclusions:

  • Understanding P-P interactions is key to unlocking new therapeutic strategies.
  • Targeting P-P interactions offers a promising avenue for novel anti-cancer drug development.
  • Continued research into P-P interaction modulation is vital for advancing cancer treatment.

Related Experiment Videos